Coronavirus Disease of 2019 (COVID-19) Health Education Initiative for School Safety
NCT ID: NCT06938230
Last Updated: 2026-01-06
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
112 participants
INTERVENTIONAL
2022-08-02
2023-06-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
COVID-19 Health Messaging to Underserved Communities
NCT04371419
Evaluating a Community-Led COVID-19 Testing Intervention to Address Mistrust - Study 1
NCT06650462
Brief Informational Intervention for COVID-19 Misinformation Prophylaxis
NCT04557241
NUYou:mHealth Intervention to Preserve and Promote Ideal Cardiovascular Health
NCT02496728
Improving COVID-19 Vaccine Uptake in Nursing Homes
NCT04732819
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Health Education Initiative
Participants will receive the health education session for up to 6 months.
Health Education Initiative
Participants will receive a one time 45 minute intervention session. During the session participants will receive information regarding COVID-19 disease process and behavioral effects and had the opportunity to ask questions.
Control Group
Participants in this group will not receive any health education and total participation is up to 6 months.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Health Education Initiative
Participants will receive a one time 45 minute intervention session. During the session participants will receive information regarding COVID-19 disease process and behavioral effects and had the opportunity to ask questions.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Arch Creek Elementary, Fulford Elementary
* Greynolds Park Elementary
* Sabal Palm Elementary
* North Miami Middle school,
* John F Kennedy (JFK) Middle School
* North Miami Senior High
* North Miami Beach High
* Booker T. Washington High
* Able to read and write in English, Spanish, or Creole at a 5th grade level
Exclusion Criteria
* English
* Spanish
* Creole
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
NIH
University of Miami
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Lisa Gwynn
Full Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Lisa Gwynn, DO
Role: PRINCIPAL_INVESTIGATOR
University of Miami
Elizabeth Pulgaron, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Miami
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Miami
Miami, Florida, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol
Document Type: Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
20220254
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.